Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias

There is no standard or widely effective treatment of patients with moderate aplastic anemia (MAA) or hypo-productive uni-lineage cytopenias (UC). Eltrombopag (EPAG), a small molecule thrombopoietin mimetic, has previously been shown to result in durable multi-lineage hematologic responses with low...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Fan, Xing, Desmond, Ronan, Winkler, Thomas, Young, David J., Dumitriu, Bogdan, Townsley, Danielle M., Gutierrez-Rodrigues, Fernanda, Lotter, Jennifer, Valdez, Janet, Sellers, Stephanie E., Barranta, Ma Evette, Shalhoub, Ruba N., Wu, Colin O., Albitar, Maher, Calvo, Katherine R., Young, Neal S., Dunbar, Cynthia E.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Hematopoiesis and Stem Cells
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7189303/
https://ncbi.nlm.nih.gov/pubmed/32330244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001657
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars